Sunday, July 28, 2019

This week in Pharma: Potential Pfizer-Mylan deal could begin consolidation of generic industry

This week in Pharma: Potential Pfizer-Mylan deal could begin consolidation of generic industry The combined entity after the merger of Pfizer#39;s off-patent business and Mylan would become the largest generic drug maker globally, and may set the pace for the consolidation of an industry facing pricing pressure amidst competition and channel consolidation in US market.

from Moneycontrol Business News https://ift.tt/2Yda5kf
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...